5L6N image
Deposition Date 2016-05-30
Release Date 2017-03-29
Last Version Date 2024-10-16
Entry Detail
PDB ID:
5L6N
Keywords:
Title:
Disulfated madanin-thrombin complex
Biological Source:
Source Organism:
Method Details:
Experimental Method:
Resolution:
1.63 Å
R-Value Free:
0.19
R-Value Work:
0.16
R-Value Observed:
0.16
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Prothrombin
Gene (Uniprot):F2
Chain IDs:B (auth: H)
Chain Length:259
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Thrombin inhibitor madanin 1
Chain IDs:C (auth: I)
Chain Length:35
Number of Molecules:1
Biological Source:Haemaphysalis longicornis
Polymer Type:polypeptide(L)
Molecule:Prothrombin
Gene (Uniprot):F2
Chain IDs:A (auth: L)
Chain Length:36
Number of Molecules:1
Biological Source:Homo sapiens
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
TYS C TYR modified residue
Primary Citation
Tyrosine sulfation modulates activity of tick-derived thrombin inhibitors.
Nat Chem 9 909 917 (2017)
PMID: 28837178 DOI: 10.1038/nchem.2744

Abstact

Madanin-1 and chimadanin are two small cysteine-free thrombin inhibitors that facilitate blood feeding in the tick Haemaphysalis longicornis. Here, we report a post-translational modification-tyrosine sulfation-of these two proteins that is critical for potent anti-thrombotic and anticoagulant activity. Inhibitors produced in baculovirus-infected insect cells displayed heterogeneous sulfation of two tyrosine residues within each of the proteins. One-pot ligation-desulfurization chemistry enabled access to homogeneous samples of all possible sulfated variants of the proteins. Tyrosine sulfation of madanin-1 and chimadanin proved crucial for thrombin inhibitory activity, with the doubly sulfated variants three orders of magnitude more potent than the unmodified inhibitors. The three-dimensional structure of madanin-1 in complex with thrombin revealed a unique mode of inhibition, with the sulfated tyrosine residues binding to the basic exosite II of the protease. The importance of tyrosine sulfation within this family of thrombin inhibitors, together with their unique binding mode, paves the way for the development of anti-thrombotic drug leads based on these privileged scaffolds.

Legend

Protein

Chemical

Disease

Primary Citation of related structures